Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parkinson Disease | 11 | 2025 | 47 | 4.720 |
Why?
|
| Stroke | 7 | 2026 | 261 | 1.850 |
Why?
|
| Range of Motion, Articular | 5 | 2020 | 63 | 1.630 |
Why?
|
| Gait Disorders, Neurologic | 4 | 2020 | 9 | 1.340 |
Why?
|
| Postural Balance | 3 | 2024 | 44 | 1.330 |
Why?
|
| Transcranial Direct Current Stimulation | 6 | 2022 | 16 | 1.300 |
Why?
|
| Osteoarthritis, Knee | 3 | 2025 | 26 | 1.270 |
Why?
|
| Dancing | 3 | 2024 | 16 | 1.140 |
Why?
|
| Pain Measurement | 2 | 2025 | 172 | 1.060 |
Why?
|
| Dance Therapy | 2 | 2024 | 3 | 1.020 |
Why?
|
| Physical Stimulation | 4 | 2020 | 72 | 0.970 |
Why?
|
| Naproxen | 1 | 2025 | 15 | 0.930 |
Why?
|
| Terminology as Topic | 1 | 2026 | 64 | 0.910 |
Why?
|
| Heart-Assist Devices | 1 | 2026 | 38 | 0.900 |
Why?
|
| Ventricular Function, Left | 1 | 2026 | 115 | 0.890 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2025 | 79 | 0.890 |
Why?
|
| Aged | 19 | 2026 | 5647 | 0.870 |
Why?
|
| Gait | 4 | 2020 | 61 | 0.840 |
Why?
|
| Heart Failure | 1 | 2026 | 254 | 0.770 |
Why?
|
| Walking | 2 | 2020 | 136 | 0.720 |
Why?
|
| Middle Aged | 20 | 2026 | 7493 | 0.710 |
Why?
|
| Insulin Resistance | 1 | 2023 | 176 | 0.680 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2023 | 125 | 0.670 |
Why?
|
| Humans | 33 | 2026 | 29202 | 0.660 |
Why?
|
| Carotid Artery Diseases | 1 | 2020 | 37 | 0.640 |
Why?
|
| Secondary Prevention | 1 | 2020 | 46 | 0.630 |
Why?
|
| Ischemic Attack, Transient | 1 | 2020 | 26 | 0.630 |
Why?
|
| Leg | 1 | 2020 | 134 | 0.620 |
Why?
|
| Quality of Life | 3 | 2023 | 523 | 0.610 |
Why?
|
| Female | 22 | 2026 | 15819 | 0.600 |
Why?
|
| Aspirin | 1 | 2020 | 125 | 0.600 |
Why?
|
| Hydrotherapy | 1 | 2019 | 3 | 0.590 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2020 | 191 | 0.580 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 346 | 0.570 |
Why?
|
| Movement | 1 | 2019 | 100 | 0.570 |
Why?
|
| Double-Blind Method | 8 | 2025 | 426 | 0.570 |
Why?
|
| Male | 20 | 2026 | 14120 | 0.570 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 384 | 0.560 |
Why?
|
| Neurological Rehabilitation | 1 | 2018 | 3 | 0.560 |
Why?
|
| Pain Management | 1 | 2018 | 66 | 0.530 |
Why?
|
| Treatment Outcome | 8 | 2026 | 2442 | 0.520 |
Why?
|
| Chronic Pain | 1 | 2018 | 63 | 0.510 |
Why?
|
| Neuralgia | 3 | 2024 | 19 | 0.510 |
Why?
|
| Risk Factors | 5 | 2026 | 2144 | 0.470 |
Why?
|
| Reproducibility of Results | 4 | 2026 | 794 | 0.400 |
Why?
|
| Retrospective Studies | 6 | 2026 | 2659 | 0.400 |
Why?
|
| Cognitive Dysfunction | 2 | 2024 | 271 | 0.330 |
Why?
|
| Aged, 80 and over | 7 | 2025 | 2070 | 0.310 |
Why?
|
| Phantom Limb | 2 | 2020 | 9 | 0.310 |
Why?
|
| Time Factors | 2 | 2026 | 1619 | 0.300 |
Why?
|
| Foot | 2 | 2020 | 23 | 0.290 |
Why?
|
| Stroke Rehabilitation | 3 | 2022 | 14 | 0.250 |
Why?
|
| Spinal Cord Injuries | 2 | 2018 | 69 | 0.250 |
Why?
|
| Cerebrovascular Circulation | 2 | 2025 | 227 | 0.250 |
Why?
|
| Chicago | 1 | 2026 | 9 | 0.240 |
Why?
|
| Observer Variation | 1 | 2026 | 46 | 0.240 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2025 | 6 | 0.230 |
Why?
|
| Neurovascular Coupling | 2 | 2024 | 154 | 0.230 |
Why?
|
| Cross-Sectional Studies | 4 | 2024 | 1012 | 0.230 |
Why?
|
| Self-Help Devices | 1 | 2025 | 4 | 0.220 |
Why?
|
| Cognition | 2 | 2025 | 331 | 0.220 |
Why?
|
| Niacinamide | 1 | 2025 | 32 | 0.220 |
Why?
|
| Predictive Value of Tests | 1 | 2026 | 485 | 0.210 |
Why?
|
| NAD | 1 | 2025 | 104 | 0.210 |
Why?
|
| Hyperalgesia | 1 | 2024 | 16 | 0.210 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2024 | 38 | 0.210 |
Why?
|
| Recurrence | 2 | 2025 | 328 | 0.200 |
Why?
|
| Motor Cortex | 2 | 2021 | 48 | 0.200 |
Why?
|
| Pain, Postoperative | 1 | 2024 | 62 | 0.200 |
Why?
|
| Risk Assessment | 1 | 2026 | 632 | 0.200 |
Why?
|
| Pain Threshold | 1 | 2024 | 89 | 0.200 |
Why?
|
| Cerebral Small Vessel Diseases | 1 | 2023 | 14 | 0.190 |
Why?
|
| Life Style | 1 | 2023 | 91 | 0.190 |
Why?
|
| Peripheral Arterial Disease | 1 | 2025 | 144 | 0.190 |
Why?
|
| Dietary Supplements | 1 | 2025 | 274 | 0.180 |
Why?
|
| White Matter | 1 | 2023 | 90 | 0.180 |
Why?
|
| Biomechanical Phenomena | 2 | 2019 | 183 | 0.170 |
Why?
|
| Parents | 1 | 2023 | 142 | 0.170 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2023 | 845 | 0.170 |
Why?
|
| Glucose | 1 | 2023 | 209 | 0.170 |
Why?
|
| Lipids | 1 | 2023 | 220 | 0.170 |
Why?
|
| Hypertension | 1 | 2023 | 309 | 0.160 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 124 | 0.160 |
Why?
|
| Neural Pathways | 1 | 2020 | 122 | 0.150 |
Why?
|
| Mobility Limitation | 1 | 2019 | 15 | 0.150 |
Why?
|
| Comorbidity | 1 | 2020 | 261 | 0.150 |
Why?
|
| Brain Ischemia | 1 | 2020 | 88 | 0.150 |
Why?
|
| Muscle Spasticity | 1 | 2018 | 3 | 0.150 |
Why?
|
| Muscle Stretching Exercises | 1 | 2018 | 20 | 0.140 |
Why?
|
| Equipment and Supplies | 1 | 2018 | 12 | 0.140 |
Why?
|
| Forefoot, Human | 1 | 2017 | 3 | 0.130 |
Why?
|
| Perceptual Disorders | 1 | 2017 | 4 | 0.130 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2017 | 14 | 0.130 |
Why?
|
| Adult | 3 | 2026 | 8125 | 0.130 |
Why?
|
| Autonomic Nervous System | 1 | 2017 | 118 | 0.120 |
Why?
|
| Surveys and Questionnaires | 1 | 2019 | 1021 | 0.110 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 645 | 0.090 |
Why?
|
| Endothelium, Vascular | 2 | 2025 | 344 | 0.090 |
Why?
|
| Pilot Projects | 2 | 2025 | 467 | 0.080 |
Why?
|
| Amputees | 2 | 2020 | 7 | 0.080 |
Why?
|
| Recovery of Function | 2 | 2018 | 123 | 0.070 |
Why?
|
| Perfusion Imaging | 1 | 2025 | 10 | 0.060 |
Why?
|
| Pyridinium Compounds | 1 | 2025 | 27 | 0.060 |
Why?
|
| Administration, Oral | 1 | 2025 | 191 | 0.050 |
Why?
|
| Accidental Falls | 1 | 2024 | 36 | 0.050 |
Why?
|
| Interviews as Topic | 1 | 2025 | 164 | 0.050 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2024 | 75 | 0.050 |
Why?
|
| Equipment Design | 1 | 2025 | 218 | 0.050 |
Why?
|
| Fasting | 1 | 2024 | 91 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2024 | 233 | 0.050 |
Why?
|
| Muscle Strength | 1 | 2024 | 230 | 0.050 |
Why?
|
| Paresis | 1 | 2022 | 9 | 0.050 |
Why?
|
| Cerebral Hemorrhage | 1 | 2023 | 93 | 0.050 |
Why?
|
| Prognosis | 1 | 2024 | 817 | 0.040 |
Why?
|
| Mitochondria | 1 | 2025 | 419 | 0.040 |
Why?
|
| Diagnostic Errors | 1 | 2021 | 32 | 0.040 |
Why?
|
| Telemedicine | 1 | 2024 | 228 | 0.040 |
Why?
|
| Hand | 1 | 2021 | 26 | 0.040 |
Why?
|
| Young Adult | 2 | 2020 | 2875 | 0.040 |
Why?
|
| Chile | 1 | 2020 | 9 | 0.040 |
Why?
|
| Latin America | 1 | 2020 | 9 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2025 | 692 | 0.040 |
Why?
|
| Thrombectomy | 1 | 2020 | 30 | 0.040 |
Why?
|
| Basal Ganglia | 1 | 2020 | 10 | 0.040 |
Why?
|
| Amputation | 1 | 2020 | 42 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 121 | 0.040 |
Why?
|
| Lower Extremity | 1 | 2020 | 85 | 0.040 |
Why?
|
| Video Recording | 1 | 2019 | 41 | 0.040 |
Why?
|
| Arm | 1 | 2018 | 37 | 0.040 |
Why?
|
| Pain | 1 | 2021 | 258 | 0.040 |
Why?
|
| Pressure | 1 | 2018 | 91 | 0.030 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2018 | 22 | 0.030 |
Why?
|
| Rotation | 1 | 2017 | 9 | 0.030 |
Why?
|
| Ankle Joint | 1 | 2017 | 16 | 0.030 |
Why?
|
| Hip Joint | 1 | 2017 | 19 | 0.030 |
Why?
|
| Hydrocortisone | 1 | 2018 | 89 | 0.030 |
Why?
|
| Aging | 1 | 2024 | 1041 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2017 | 107 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2017 | 139 | 0.030 |
Why?
|
| Muscle Contraction | 1 | 2017 | 175 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2017 | 393 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 741 | 0.030 |
Why?
|
| Heart Rate | 1 | 2017 | 383 | 0.030 |
Why?
|